Stock listing
FBIO Stock Price, News, Filings & Events — Fortress Biotech, Inc.
Selected listing: FBIO · NASDAQ · USD · US
This page tracks Fortress Biotech, Inc.'s FBIO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following FBIO:NASDAQ. FBIO:NASDAQ is the stock-level entry point for investors researching Fortress Biotech, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Fortress Biotech, Inc. (ticker: FBIO) is a public company based in the United States with a market capitalization of approximately $111 million. The company focuses on developing and commercializing innovative pharmaceutical and biotechnology products. Fortress Biotech aims to advance its portfolio through strategic partnerships and collaborations within the healthcare sector.

- Ticker
- FBIO:NASDAQ
- Asset type
- Stock
- Market cap
- $84.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Fortress Biotech, Inc. FBIO:NASDAQ stock context
This page tracks Fortress Biotech, Inc.'s FBIO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following FBIO:NASDAQ. FBIO:NASDAQ is the stock-level entry point for investors researching Fortress Biotech, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Fortress Biotech, Inc. (ticker: FBIO) is a public company based in the United States with a market capitalization of approximately $111 million. The company focuses on developing and commercializing innovative pharmaceutical and biotechnology products. Fortress Biotech aims to advance its portfolio through strategic partnerships and collaborations within the healthcare sector.
Latest news from Fortress Biotech, Inc.
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 13, 2026
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics $130 Million Series B Financing
July 28, 2026
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
July 27, 2026
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 18, 2026
Fortress Biotech, Inc. earnings calls
Research Fortress Biotech, Inc.
Fortress Biotech, Inc. investor report
Review AI stock analysis and investor report context for FBIO:NASDAQ.
Fortress Biotech, Inc. company profile
View the public company page for Fortress Biotech, Inc. on 6ix.
Fortress Biotech, Inc. news
Read company news and market updates connected to Fortress Biotech, Inc..
Fortress Biotech, Inc. investor events
Find investor webinars, events, and replay context for Fortress Biotech, Inc..
Alternate listings
FBIOP:NASDAQ
US · USD
Alternate listing for Fortress Biotech, Inc.; the primary context on this page is FBIO:NASDAQ.
FBIOP:BOATS
US · USD
Alternate listing for Fortress Biotech, Inc.; the primary context on this page is FBIO:NASDAQ.
FBIO:BOATS
US · USD
Alternate listing for Fortress Biotech, Inc.; the primary context on this page is FBIO:NASDAQ.